[go: up one dir, main page]

FI930051A0 - 4,13-dioxabicyklo(8.2.1)tridecenonderivat sam foerfarande och mellanprodukt foer deras framstaellning - Google Patents

4,13-dioxabicyklo(8.2.1)tridecenonderivat sam foerfarande och mellanprodukt foer deras framstaellning

Info

Publication number
FI930051A0
FI930051A0 FI930051A FI930051A FI930051A0 FI 930051 A0 FI930051 A0 FI 930051A0 FI 930051 A FI930051 A FI 930051A FI 930051 A FI930051 A FI 930051A FI 930051 A0 FI930051 A0 FI 930051A0
Authority
FI
Finland
Prior art keywords
tridecenonderivat
dioxabicyclo
sam
foerfarande och
deras framstaellning
Prior art date
Application number
FI930051A
Other languages
English (en)
Other versions
FI930051L (fi
FI106862B (fi
Inventor
Dagmar Hoeltje
Ulf Preuschoff
Christian Eeckhout
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of FI930051A0 publication Critical patent/FI930051A0/fi
Publication of FI930051L publication Critical patent/FI930051L/fi
Application granted granted Critical
Publication of FI106862B publication Critical patent/FI106862B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
FI930051A 1992-01-07 1993-01-07 Menetelmä 4,13-dioksabisyklo[8.2.1]tridekenonijohdannaisten ja niiden välituotteiden valmistamiseksi FI106862B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4200145 1992-01-07
DE4200145A DE4200145A1 (de) 1992-01-07 1992-01-07 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (3)

Publication Number Publication Date
FI930051A0 true FI930051A0 (fi) 1993-01-07
FI930051L FI930051L (fi) 1993-07-08
FI106862B FI106862B (fi) 2001-04-30

Family

ID=6449136

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930051A FI106862B (fi) 1992-01-07 1993-01-07 Menetelmä 4,13-dioksabisyklo[8.2.1]tridekenonijohdannaisten ja niiden välituotteiden valmistamiseksi

Country Status (27)

Country Link
US (1) US5418224A (fi)
EP (1) EP0550895B1 (fi)
JP (1) JP3300084B2 (fi)
KR (1) KR100273937B1 (fi)
CN (1) CN1033646C (fi)
AT (1) ATE155478T1 (fi)
AU (1) AU667699B2 (fi)
CA (1) CA2086811C (fi)
CZ (1) CZ281773B6 (fi)
DE (2) DE4200145A1 (fi)
DK (1) DK0550895T3 (fi)
DZ (1) DZ1652A1 (fi)
ES (1) ES2104808T3 (fi)
FI (1) FI106862B (fi)
GR (1) GR3024859T3 (fi)
HU (2) HU212272B (fi)
IL (1) IL104158A (fi)
LT (1) LT3015B (fi)
LV (1) LV10458B (fi)
MX (1) MX9300045A (fi)
NO (1) NO179586C (fi)
PH (1) PH30098A (fi)
RU (1) RU2107070C1 (fi)
SK (1) SK279251B6 (fi)
TW (1) TW238308B (fi)
UA (1) UA29393C2 (fi)
ZA (1) ZA9339B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2233541C (en) * 1995-10-13 2002-04-30 Neurosearch A/S 8-azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use
EP0884322A4 (en) * 1996-03-01 2002-04-24 Takeda Chemical Industries Ltd METHOD FOR PRODUCING ERYTHROMYCIN DERIVATIVES
US6077943A (en) * 1996-03-01 2000-06-20 Takeda Chemical Industries, Ltd. Method of producing erythromycin derivative
DE19644195A1 (de) * 1996-10-24 1998-04-30 Solvay Pharm Gmbh 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US6165985A (en) * 1998-02-13 2000-12-26 Solvay Pharmaceuticals Gmbh 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them
DE19805822B4 (de) * 1998-02-13 2009-02-05 Solvay Pharmaceuticals Gmbh 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
HRP980496B1 (en) * 1998-09-10 2007-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. New thilozine hydroxy derivatives and a process for the preparation thereof
ES2261224T3 (es) 2000-08-17 2006-11-16 The Kitasato Institute Nuevos derivados de pseudoeritromicina.
JP3944077B2 (ja) * 2000-09-01 2007-07-11 中外製薬株式会社 エリスロマイシン誘導体の製造方法
WO2002092592A1 (de) * 2001-05-10 2002-11-21 Solvay Pharmaceuticals Gmbh Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US20040067896A1 (en) * 2002-07-25 2004-04-08 The Kitasato Institute Novel pseudoerythromycin derivatives
DE602004025569D1 (de) 2003-06-18 2010-04-01 Tranzyme Pharma Inc Makrozyklische motilin rezeptorantagonisten
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
JP2009518396A (ja) * 2005-12-08 2009-05-07 ファイザー・インク エリスロマイシン化合物の3’−ジメチルアミノ基を脱メチルする方法
CA2662897C (en) 2006-09-11 2017-11-07 Tranzyme Pharma, Inc. Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
MX2009005977A (es) * 2006-12-05 2009-06-17 Pfizer Polimorfos de motilida.
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex
EP2979702A4 (en) * 2013-03-25 2016-11-16 Zeria Pharm Co Ltd GASTROKINETIC POSTPRANDIAL MEDIUM

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725385A (en) * 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
CA1321581C (en) * 1987-05-26 1993-08-24 Herbert A. Kirst Ring-contracted macrolides
US5106961A (en) * 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
US4920102A (en) 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders

Also Published As

Publication number Publication date
IL104158A (en) 1997-07-13
LV10458A (lv) 1995-02-20
EP0550895B1 (de) 1997-07-16
CZ341492A3 (en) 1993-07-14
NO930029D0 (no) 1993-01-06
LV10458B (en) 1996-02-20
CA2086811A1 (en) 1993-07-08
ATE155478T1 (de) 1997-08-15
CA2086811C (en) 2003-12-09
US5418224A (en) 1995-05-23
HK1014003A1 (en) 1999-09-17
GR3024859T3 (en) 1998-01-30
EP0550895A1 (de) 1993-07-14
KR100273937B1 (ko) 2000-12-15
TW238308B (fi) 1995-01-11
CN1033646C (zh) 1996-12-25
SK341492A3 (en) 1995-05-10
IL104158A0 (en) 1993-05-13
MX9300045A (es) 1993-12-01
HU210216A9 (en) 1995-02-28
PH30098A (en) 1996-12-27
LT3015B (lt) 1994-08-25
CZ281773B6 (cs) 1997-01-15
FI930051L (fi) 1993-07-08
ZA9339B (en) 1993-08-05
NO930029L (no) 1993-07-08
ES2104808T3 (es) 1997-10-16
AU3103693A (en) 1993-07-08
NO179586B (no) 1996-07-29
HU9204076D0 (en) 1993-04-28
DE59208710D1 (de) 1997-08-21
LTIP187A (lt) 1994-03-25
AU667699B2 (en) 1996-04-04
RU2107070C1 (ru) 1998-03-20
SK279251B6 (sk) 1998-08-05
DE4200145A1 (de) 1993-07-08
JP3300084B2 (ja) 2002-07-08
HUT66234A (en) 1994-10-28
KR930016436A (ko) 1993-08-26
FI106862B (fi) 2001-04-30
DZ1652A1 (fr) 2002-02-17
CN1075320A (zh) 1993-08-18
HU212272B (en) 1996-04-29
DK0550895T3 (da) 1997-08-25
UA29393C2 (uk) 2000-11-15
NO179586C (no) 1996-11-06
JPH07247299A (ja) 1995-09-26

Similar Documents

Publication Publication Date Title
FI930051A0 (fi) 4,13-dioxabicyklo(8.2.1)tridecenonderivat sam foerfarande och mellanprodukt foer deras framstaellning
FI911330L (fi) 1,4,7,10-tetra-azacyklododekan -butyltrioler, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska aemnen.
FI921113A0 (fi) Foerfarande och anordning foer kontroll av pulsbreddsmodulatorns (pwm) omvandlare.
FI921943L (fi) Poroest bikaksmaterial, foerfarande foer framstaellning av det och anvaendning av det
FI925673L (fi) Anvaendning av 5,10,15,20-tetrakis(r-karboxifenyl)porfin foer detektering och behandling av lungcancer
FI915876A7 (fi) Direkt kompressibel pulverformig sammansaettning och foerfarande foer att erhaolla en saodan.
FI914487A0 (fi) 1,3-bensoxazinderivat, deras framstaellning och anvaendning.
FI933598A7 (fi) Anordning och foerfarande foer direkt fasdigitering
FI912138A7 (fi) Luftvaexlingssystem foer andningsskydd och andningsskydd.
FI933065L (fi) Foerfarande foer framstaellning av azabicyklo (2.2.2)oktan-3-iminer och foerfarandet anvaenda mellanprodukter
FI923458L (fi) 4,5-cykloalkano-3-benzazepin-7-ol- derivat och deras anvaendning.
FI920400L (fi) 2,5-diaryl-1,3,4-oxadiazol-hydroxiester, -hydroxiester,-hydroxisyra och -acetoxiester och deras syntesmetod.
FI933605A0 (fi) Sammansaettningar av 1-klor-2,2,2-trifluoretyldifluormetyleter och partiellt fluorerade alkanoler
FI925111L (fi) Substituerade 1,5-pentadioler och foerfarande foer deras framstaellning
FI920247A7 (fi) Foerfarande foer framstaellning av n-imidazolylderivat av substituerade tetrahydrokarbazoler och cyklohept(b)indoler.
FI924756A0 (fi) 1,5-benzotiazepinonderivat, deras framstaellning och farmaceutiska anvaendning
FI912269A7 (fi) 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa.
FI911567A7 (fi) Anvaendning av dermatansulfat foer foerebyggande och vaord av aoldrande av hjaernan och insufficienstillstaond i det centrala nervsystemet.
FI911660A0 (fi) Foerfarande och odlingsenhet foer odling.
FI910197A0 (fi) Foerfarande och anordning foer skogsgallring.
FI924577L (fi) Foerfarande foer framstaellning av 1,2,4-trifluorbenzen och 1-klor-3,4-difluorbenzen
FI911382A0 (fi) Regleringsfoerfarande och regleringskrets foer en laserdiodsaendare.
FI915566L (fi) B-hydroxietylaminer, vilka innehaoller en 1,1-disubstituerad cyklopropylrest, foerfarande foer deras framstaellning och deras anvaendning.
FI933255L (fi) 1,4-dihydropyridin-3,5-dikarboxylsyraester, foerfarande foer framstaellning och farmaceutisk anvaendning av densamma
FI934252L (fi) 1,5,6,7-tetrahydro-4H-indazol-4-oner innehaollande laekemedel, nya 1,5,6,7-tetrahydro-4H-indazol-4-oner och foerfarande foer deras framstaellning

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: SOLVAY PHARMACEUTICALS GMBH